164 related articles for article (PubMed ID: 18046612)
1. Surgical treatment of primary neuroendocrine tumors of the liver.
Hwang S; Lee YJ; Lee SG; Kim CW; Kim KH; Ahn CS; Moon KM; Ko KH; Kim KW; Choi NK; Ha TY
J Gastrointest Surg; 2008 Apr; 12(4):725-30. PubMed ID: 18046612
[TBL] [Abstract][Full Text] [Related]
2. Long-term postresection prognosis of primary neuroendocrine tumors of the liver.
Jung J; Hwang S; Hong SM; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Park YH
Ann Surg Treat Res; 2019 Oct; 97(4):176-183. PubMed ID: 31620391
[TBL] [Abstract][Full Text] [Related]
3. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
[TBL] [Abstract][Full Text] [Related]
5. Treatment of liver metastases in patients with neuroendocrine tumors.
Frilling A; Rogiers X; Malagó M; Liedke OM; Kaun M; Broelsch CE
Langenbecks Arch Surg; 1998 Mar; 383(1):62-70. PubMed ID: 9627173
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for metastatic neuroendocrine tumors.
Lang H; Oldhafer KJ; Weimann A; Schlitt HJ; Scheumann GF; Flemming P; Ringe B; Pichlmayr R
Ann Surg; 1997 Apr; 225(4):347-54. PubMed ID: 9114792
[TBL] [Abstract][Full Text] [Related]
7. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
[TBL] [Abstract][Full Text] [Related]
8. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
10. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
[TBL] [Abstract][Full Text] [Related]
11. Primary hepatic neuroendocrine neoplasm: Long-time surgical outcome and prognosis.
Shi C; Zhao Q; Dai B; Xie F; Yang J
Medicine (Baltimore); 2018 Aug; 97(31):e11764. PubMed ID: 30075602
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for short recurrence-free survival after resection of pancreatic neuroendocrine tumor (PanNET) liver metastases: which patients should undergo resection?
Masui T; Nagai K; Anazawa T; Kasai Y; Sato A; Nakano K; Uchida Y; Yogo A; Kawaguchi Y; Takaori K; Uemoto S
Scand J Gastroenterol; 2020 Apr; 55(4):479-484. PubMed ID: 32223573
[No Abstract] [Full Text] [Related]
13. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
[TBL] [Abstract][Full Text] [Related]
14. Primary hepatic neuroendocrine tumor: successful hepatectomy in two cases and review of the literature.
Rückert RI; Rückert JC; Dörffel Y; Rudolph B; Müller JM
Digestion; 1999; 60(2):110-6. PubMed ID: 10095151
[TBL] [Abstract][Full Text] [Related]
15. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation.
Saxena A; Chua TC; Chu F; Al-Zahrani A; Morris DL
Am J Clin Oncol; 2012 Oct; 35(5):439-45. PubMed ID: 21654315
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for unresectable neuroendocrine tumor liver metastases.
Rossi RE; Burroughs AK; Caplin ME
Ann Surg Oncol; 2014 Jul; 21(7):2398-405. PubMed ID: 24562931
[TBL] [Abstract][Full Text] [Related]
18. Surgical strategy for liver metastases of neuroendocrine tumors.
Tsuchikawa T; Hirano S; Tanaka E; Kato K; Matsumoto J; Nakayama T; Tabata Y; Shichinohe T
Hepatogastroenterology; 2012 May; 59(115):921-3. PubMed ID: 22024223
[TBL] [Abstract][Full Text] [Related]
19. [Principles of curative resection of liver metastases].
Schlag PM; Benhidjeb T; Kilpert B
Chirurg; 1999 Feb; 70(2):123-32. PubMed ID: 10097851
[TBL] [Abstract][Full Text] [Related]
20. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
